| Identification | Back Directory | [Name]
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- | [CAS]
2748157-34-6 | [Synonyms]
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- | [Molecular Formula]
C20H25N3O5 | [MOL File]
2748157-34-6.mol | [Molecular Weight]
387.43 |
| Hazard Information | Back Directory | [Description]
AB-CHMINACA is a synthetic cannabinoid (CB) that is an analog of AB-FUBINACA , a potent agonist of the central CB1 receptor (Ki = 0.9 nM).1,2 AB-CHMINACA metabolite M7 is a potential metabolite produced during metabolism of AB-CHMINACA in vivo. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. | [References]
1. Uchiyama, N., Matsuda, S., Wakana, D., et al. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products Forensic Toxicol. 31(1),93-100(2013).
2. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives ,1-283(2009). |
|
|